Market Place
Sourcing Support
America’s drug price hike conundrum in backdrop of 2019 Medicare Part D data
Nearly every
year, drugmakers ring in the new year with drug price increases in the US. This
year
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
The Next Generic Attack: Brilinta® (Ticagrelor), Xarelto® (Rivaroxaban), Tradjenta® (Linagliptin) and…
With almost 30,000 Drug Master Files (DMFs) submitted to the
FDA, reviewing the filings of only the
